SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT [Schedule] Condensed Statements of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income (loss)	$ (13,194)	$ (30,395)	$ (5,335)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation	1,325	2,090	2,574
Other, net	354	562	481
Changes in assets and liabilities, net of effect of dispositions:
(Increase) decrease in prepaid and other assets	(1,731)	1,227	3,448
Increase (decrease) in accounts payable, accrued expenses and other liabilities	4,213	(2,100)	(22,452)
Increase (decrease) in accrued business reorganization expenses	2,684	818	1,878
Net cash provided by (used in) operating activities	(17,840)	2,513	13,159
Cash flows from investing activities:
Capital expenditures	(5,346)	(2,557)	(8,647)
Net cash provided by (used in) investing activities	16,731	(2,557)	(8,272)
Cash flows from financing activities:
Borrowings under credit agreements	133,030	17,314	74,534
Purchase of restricted stock from employees	(138)	(488)	(600)
Net cash provided by (used in) financing activities	(1,256)	(497)	(4,274)
Net (decrease) increase in cash and cash equivalents	(3,389)	(1,275)	1,351
Cash and cash equivalents, beginning of the period	37,378	38,653	37,302
Cash and cash equivalents, end of the period	33,989	37,378	38,653
Parent Company
Cash flows from operating activities:
Net income (loss)	(13,194)	(30,395)	(5,335)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Dividends received from subsidiaries	0	2,341	6,255
Non-cash (income) losses from subsidiaries, net of taxes	2,995	22,522	1,103
Depreciation and amortization	541	645	641
Stock-based compensation	405	953	1,479
Other, net	248	368	368
Changes in assets and liabilities, net of effect of dispositions:
(Increase) decrease in prepaid and other assets	(744)	144	1,151
(Increase) decrease in due from subsidiaries	11,910	10,409	(6,736)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	837	(1,597)	(2,443)
Increase (decrease) in accrued business reorganization expenses	793	134	40
Net cash provided by (used in) operating activities	3,791	5,524	(3,477)
Cash flows from investing activities:
Capital expenditures	0	(368)	(76)
Advances to and investments in subsidiaries, net	(4,126)	(6,673)	0
Net cash provided by (used in) investing activities	(4,126)	(7,041)	(76)
Cash flows from financing activities:
Borrowings under credit agreements	22,081	514	6,862
Repayments under credit facility	(22,081)	(514)	(6,862)
Purchase of restricted stock from employees	(129)	(488)	(600)
Net cash provided by (used in) financing activities	(129)	(488)	(600)
Net (decrease) increase in cash and cash equivalents	(464)	(2,005)	(4,153)
Cash and cash equivalents, beginning of the period	7,470	9,475	13,628
Cash and cash equivalents, end of the period	$ 7,006	$ 7,470	$ 9,475